Shulman DeMeo Asset Management LLC - ENZO BIOCHEM INC ownership

ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 41 filers reported holding ENZO BIOCHEM INC in Q2 2024. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Shulman DeMeo Asset Management LLC ownership history of ENZO BIOCHEM INC
ValueSharesWeighting
Q2 2024$16,881
-14.2%
15,4870.0%0.00%
-20.0%
Q1 2024$19,668
-8.6%
15,4870.0%0.01%
-16.7%
Q4 2023$21,527
-0.7%
15,4870.0%0.01%
-14.3%
Q3 2023$21,682
-23.9%
15,4870.0%0.01%
-22.2%
Q2 2023$28,496
-24.3%
15,4870.0%0.01%
-25.0%
Q1 2023$37,633
+69.9%
15,4870.0%0.01%
+71.4%
Q4 2022$22,146
-36.7%
15,4870.0%0.01%
-41.7%
Q3 2022$35,00015,4870.01%
Other shareholders
ENZO BIOCHEM INC shareholders Q2 2024
NameSharesValueWeighting ↓
First Light Asset Management, LLC 1,047,732$5,333,0002.30%
KOPP INVESTMENT ADVISORS LLC 232,099$1,181,0001.17%
GLOBEFLEX CAPITAL L P 225,834$1,149,0000.29%
KEMPNER CAPITAL MANAGEMENT INC. 70,001$356,0000.24%
Breithorn Capital Management 63,324$322,0000.24%
Acrospire Investment Management LLC 55,444$282,0000.19%
EAM Investors, LLC 267,368$1,361,0000.18%
Granahan Investment Management 875,002$4,454,0000.15%
Geduld E E 15,000$76,0000.08%
GILDER GAGNON HOWE & CO LLC 872,009$4,439,0000.08%
View complete list of ENZO BIOCHEM INC shareholders